Gen-Probe Shareholder Aims To Block $3.7B Hologic Deal
A Gen-Probe Inc. shareholder launched a class action in Delaware court on Friday challenging Hologic Inc.'s planned $3.7 billion buyout of the diagnostic-testing company, calling the offer opportunistic and inadequate....To view the full article, register now.
Already a subscriber? Click here to view full article